Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group

Autor: Martin A. Kennedy, Kenneth G. Saag, Alexander Noerup, William J. Taylor, Nicola Dalbeth, Angelo L. Gaffo, Lisa K. Stamp, Birthe M. Pedersen, Sabrina Mai Nielsen, Marissa Lassere, Melanie Birger Morillon, Sara K. Tedeschi, Tuhina Neogi, Robin Christensen, Geraldine M. McCarthy, Cesar Diaz-Torne, Beverley Shea, Jasvinder A. Singh, Rebecca Grainger, Abhishek Abhishek, Lee S. Simon, Peter Tugwell

Publikováno v: Morillon, M B, Christensen, R, Singh, J A, Dalbeth, N, Saag, K, Taylor, W J, Neogi, T, Kennedy, M A, Pedersen, B M, McCarthy, G M, Shea, B, Diaz-Torne, C, Tedeschi, S K, Grainger, R, Abhishek, A, Gaffo, A, Nielsen, S M, Noerup, A, Simon, L S, Lassere, M, Tugwell, P, Stamp, L K & for the OMERACTGout Working Group 2021, ' Serum Urate as a Proposed Surrogate Outcome Measure in Gout Trials : From the OMERACT Working Group. ', Seminars in Arthritis and Rheumatism, vol. 51, no. 6, pp. 1378-1385 . https://doi.org/10.1016/j.semarthrit.2021.11.004

Serum urate (SU) is the most common primary efficacy outcome in trials of urate-lowering therapies for gout. Despite this, it is not formally considered a validated surrogate outcome. In this paper we will outline the definitions of biomarkers and su

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92915991d5d5a127fba94abcbf66df05
https://pubmed.ncbi.nlm.nih.gov/34839932

Does advance care planning affect relatives' healthcare-seeking behaviour?

Autor: Noerup, Elisabeth S., Skorstengaard, Marianne Hjorth, Jensen, Anders Bonde, Guldin, Mai-Britt, Neergaard, Mette Asbjoern

Publikováno v: Progress in Palliative Care; Dec2022, Vol. 30 Issue 6, p356-363, 8p, 1 Diagram, 4 Charts

Norway

Autor: Nœrup, Sigrid

Publikováno v: Journal of the Society of Comparative Legislation, 1907 Jan 01. 8(2), 272-274.

Externí odkaz: https://www.jstor.org/stable/751840